Literature DB >> 11087658

Physical and transcriptional mapping of the 17p13.3 region that is frequently deleted in human cancer.

C Hoff1, P Seranski, J Mollenhauer, B Korn, T Detzel, R Reinhardt, J Ramser, A Poustka.   

Abstract

Studies of chromosomal losses at 17p13 have suggested the presence of at least two distinct regions for tumor suppressor genes, the TP53 region at 17p13.1 and a more distal region at 17p13.3. Within the latter region, Hypermethylated in Cancer 1 (HIC1) is located, a likely candidate for a tumor suppressor gene that has also been suggested to play a role in the pathogenesis of Miller-Diecker syndrome (MDS). However, single-gene isolation efforts have retrieved additional genes from 17p13.3 that could play a role in tumorigenesis. This indicates that the full potential of this chromosomal region with respect to disease-related genes has not yet been exhausted and that there may exist still unknown genes that contribute to tumorigenesis or to the complex MDS phenotype. To provide a basis for the systematic isolation and evaluation of such genes, we established a physical map over 1.5 Mb of 17p13.3 and assigned 29 transcriptional units within this region. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087658     DOI: 10.1006/geno.2000.6353

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  6 in total

1.  Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3.

Authors:  Carlos Cardoso; Richard J Leventer; Heather L Ward; Kazuhito Toyo-Oka; June Chung; Alyssa Gross; Christa L Martin; Judith Allanson; Daniela T Pilz; Ann H Olney; Osvaldo M Mutchinick; Shinji Hirotsune; Anthony Wynshaw-Boris; William B Dobyns; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2003-03-05       Impact factor: 11.025

Review 2.  Normal and Neoplastic Growth Suppression by the Extended Myc Network.

Authors:  Edward V Prochownik; Huabo Wang
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

3.  Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis.

Authors:  Peter J Hurlin; Zi-Qiang Zhou; Kazuhito Toyo-oka; Sara Ota; William L Walker; Shinji Hirotsune; Anthony Wynshaw-Boris
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

Review 4.  Deciphering HIC1 control pathways to reveal new avenues in cancer therapeutics.

Authors:  Brian R Rood; Dominique Leprince
Journal:  Expert Opin Ther Targets       Date:  2013-04-09       Impact factor: 6.902

5.  MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3).

Authors:  Ranjana K Kanchan; Naveenkumar Perumal; Pranita Atri; Ramakanth Chirravuri Venkata; Ishwor Thapa; David L Klinkebiel; Andrew M Donson; Deborah Perry; Michael Punsoni; Geoffrey A Talmon; Donald W Coulter; Daniel R Boue'; Matija Snuderl; Mohd W Nasser; Surinder K Batra; Rajeev Vibhakar; Sidharth Mahapatra
Journal:  Brain Pathol       Date:  2020-03-30       Impact factor: 6.508

Review 6.  Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment.

Authors:  Sutapa Ray; Nagendra K Chaturvedi; Kishor K Bhakat; Angie Rizzino; Sidharth Mahapatra
Journal:  Diagnostics (Basel)       Date:  2021-12-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.